Journal of Biological Chemistry · 2002 · 68 citations · 44 references
MedicineBiochemistryPharmacologyMolecular PharmacologyNeurochemistryNeuropharmacologyNeurotransmitter ReceptorsReceptor BindingReceptor PharmacologyReceptor PhysiologyReceptor RegulationSerotonergic Pharmacology5-Hydroxytryptamine Receptor PharmacologyAgonist ActivityConstitutive Receptor ActivityG Protein-coupled Receptor Structure-function RelationshipsG-protein-coupled ReceptorsLipid AcylationReversible ReactionsSerotonin Receptor Signaling
We have reported recently that the mouse 5-hydroxytryptamine(4a) (5-HT(4(a))) receptor undergoes dynamic palmitoylation (Ponimaskin, E. G., Schmidt, M. F., Heine, M., Bickmeyer, U., and Richter, D. W. (2001) Biochem. J. 353, 627-663). In the present study, conserved cysteine residues 328/329 in the carboxyl terminus of the 5-HT(4(a)) receptor were identified as potential acylation sites. In contrast to other palmitoylated G-protein-coupled receptors, the additional cysteine residue 386 positioned close to the COOH-terminal end of the receptor was also found to be palmitoylated. Using pulse and pulse-chase labeling techniques, we demonstrated that palmitoylation of individual cysteines is a reversible process and that agonist stimulation of the 5-HT(4(a)) receptor independently increases the rate of palmitate turnover for both acylation sites. Analysis of acylation-deficient mutants revealed that non-palmitoylated 5-HT(4(a)) receptors were indistinguishable from the wild type in their ability to interact with G(s), to stimulate the adenylyl cyclase activity and to activate cyclic nucleotide-sensitive cation channels after agonist stimulation. The most distinctive finding of the present study was the ability of palmitoylation to modulate the agonist-independent constitutive 5-HT(4(a)) receptor activity. We demonstrated that mutation of the proximal palmitoylation site (Cys(328) --> Ser/Cys(329) --> Ser) significantly increases the capacity of receptors to convert from the inactive (R) to the active (R*) form in the absence of agonist. In contrast, the rate of isomerization from R to R* for the Cys(386) --> Ser as well as for the triple, non-palmitoylated mutant (Cys(328) --> Ser/Cys(329) --> Ser/Cys(386) -->Ser) was similar to that obtained for the wild type.
44
Molecular cloning: A laboratory manual
Prescott L. Deininger · Analytical Biochemistry · 1990 · 86.2K citations
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Krzysztof Palczewski, Takashi Kumasaka, Tetsuya Hori et al. · Science · 2000 · 5.6K citations
Palmitoylation of the human β2-adrenergic receptor
Brian F. O’Dowd, Mark Hnatowich, Marc G. Caron et al. · Journal of Biological Chemistry · 1989 · 599 citations · Full text